Yale Urology recently welcomed Joseph Renzulli, MD, and Joseph Brito, MD, to its new practice location at L+M Hospital.
In addition to general adult urology care for both men and women, Dr. Renzulli and Dr. Brito provide care for patients with urologic cancers in coordination with the Smilow Cancer Hospital in Waterford and Smilow Cancer Hospital’s Prostate and Urologic Cancers Program. The duo offer laparoscopic, robotic and other minimally invasive techniques for comprehensive treatment of even the most complex urological problems and urologic cancers, including prostate, kidney, bladder and testicular cancers.
Being able to combine their medical expertise with the newest and most advanced technology ensures that patients have access to cutting-edge methodologies for treatment of urological problems right in their community – making L+M a “destination hospital” for complex urological surgical care, said Dr. Renzulli.
“Over the past 15 years, the most significant change in urologic surgery has been the continued introduction and adoption of new technologies and minimally invasive surgical techniques,” said Dr. Renzulli. “Yale New Haven Health has invested resources into bringing newly refined technology into our region, which has broader capabilities than prior generations of treatments and services. Patients no longer have to travel to receive the kind of complex urological surgical care offered elsewhere. It’s available right here in New London – right now.”
Such advanced technology includes robotics, a breakthrough platform for minimally-invasive surgery. Robotic surgery is used to perform a wide array of urologic procedures, including cystectomy, prostatectomy, and nephrectomy. This minimally invasive surgery includes less pain, blood loss, scarring and risk of infection; a shorter hospital stay; and a quicker return to normal daily activities.
Other investments include the “smart” Artemis prostate biopsy procedure, which combines high-resolution ultrasound technology with MRI imaging to create a 3D “map” showing the exact size, location and shape of suspicious prostate tumors which allows the surgeon to plan, navigate and record a prostate biopsy with pinpoint accuracy so patients receive an accurate prostate biopsy in an outpatient visit.
“As members of the Yale Urology faculty, it’s an easy and seamless flow to connect patients with specialists should they need services for fertility or gynecology,” Brito said. “Furthermore, we can access clinical trials at Yale Cancer Center through Smilow Cancer Hospital, which is a major benefit to patients.”